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Abstract
Background: Summer acupoint herbal patching (SAHP) has been widely used in China for thousands of years. This
bibliometric analysis aims to provide a comprehensive review of the characteristics of clinical studies on SAHP for any
condition.
Methods: We included clinical studies such as randomized clinical trials (RCTs), controlled clinical studies (CCTs), case
series (CSs), case reports (CRs), and cross-sectional studies on SAHP for any condition. Six databases were searched
from date of inception to March 2015. Bibliometric information and study details such as study type, characteristics of
participants, details of the intervention and comparison, and outcome were extracted and analyzed.
Results: A total of 937 clinical studies were identified and which were published between 1977 and 2015. This
included 404 RCTs, 52 CCTs, 458 CSs, 19 CRs and 4 cross-sectional studies and involved 232,138 participants aged 2 to
90 years from two countries. Almost all studies were from China (936, 99.89 %). The five conditions most commonly
treated by SAHP were asthma (401, 42.80 %), chronic bronchitis (146, 15.58 %), allergic rhinitis (117, 12.49 %), chronic
obstructive pulmonary disease (73, 7.79 %), and recurrent respiratory tract infection (42, 4.48 %). Among 502 controlled
studies, the majority compared SAHP alone with different controls (16 categories, 275 comparisons). The most
commonly used controls were western medicine, placebo, traditional Chinese medicine, no treatment and
non-pharmaceutical traditional Chinese therapies. Composite outcome measures were the most frequently
reported outcome (512, 69.19 %).
Conclusion: A substantial amount of research on SAHP has been published in China and which
predominantly focuses on respiratory conditions. The findings from this study can be used to inform further
research by highlighting areas of greatest impact for SAHP.
Keywords: Summer acupoint herbal patching, Sanfutie, Traditional Chinese therapies, Bibliometrics, literature
review
Background
Acupoint herbal patching (AHP) is the application of
herbal preparations to acupuncture points and is used
for the prevention, as well as treatment, of various con-
ditions in traditional Chinese medicine (TCM). The use
of AHP was first recorded in the Prescriptions for Fifty-
two Diseases (Wu Shi Er Bing Fang), written in approxi-
mately the fourth century BC and considered the oldest
herbal text in TCM [1]. A variation of AHP exists called
summer acupoint herbal patching (SAHP) which refers
to AHP applied only during the summer and which was
first described in the Zhang Shi Yi Tong text by Zhang
Lu (Qing Dynasty, 1644–1912) [2]. SAHP is also known
as sanfutie in Chinese and is commonly applied during
sanfu in the lunar calendar [3]. Sanfu refers to three spe-
cific periods in the lunar calendar and it is during these
three periods (each includes ten days) that SAHP is ap-
plied [4]. Since the 1950s, Zhang Lu’s classic approaches
have been applied in modern clinical contexts and SAHP
has become increasingly popular in China owing to its
convenience and non-invasive nature [2]. In 2014, the
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reported the use of SAHP in 620 medical institutions in
Beijing, an increase of 13.14 % compared with 2013 [5, 6].
SAHP is considered a complex therapy as it uses both
herbal medicine and acupuncture points. During SAHP,
herbs with warm and acrid properties are thought in
TCM to be more likely absorbed percutaneously and
which in turn stimulates the meridian qi. Animal experi-
ments suggest that the mechanism of AHP may be re-
lated to reducing serum IgE and IL-4 levels, restraining
the release of inflammatory mediators, and adjusting the
expression level of transcription factors in the rat model
of asthma [7, 8]. This purpose of AHP is to regulate the
functions of the body and strengthen the self-healing
capacity of the body so as to prevent and treat disease
[9–11]. However in SAHP, this effect is further enhanced
through the specific application during sanfu based on the
TCM treatment principle of ‘treating winter disease in
summer’. The rationale behind this treatment principle is
that some conditions occur during winter predominantly
due to a deficiency of yang qi, levels of which peak during
the summer and especially during the sanfu. Thus TCM
theory holds that by applying AHP during these 3 days,
patients can maximize yang qi and in turn prevent recur-
rence of a winter condition [3].
Owing to its growing popularity, we are interested in ex-
ploring SAHP further as a potential treatment. To assist
in developing appropriate areas of investigation and to for-
mulate relevant research questions, we wished to initially
identify which conditions in particular SAHP appears to
be used for, and furthermore to obtain an overview of the
study designs used. To date, 3 Chinese-language articles
have been published in 2010 but which only analyze se-
lected acupoints and herbal ingredients of SAHP [12–14].
Since there was a limited scope within these publications,
only a minimal amount of information is presented re-
garding application of SAHP. Our aim in this study there-
fore was to conduct a comprehensive bibliometric analysis
of all clinical studies featuring SAHP.
Methods
Eligibility criteria
We included all types of clinical studies including ran-
domized controlled trials (RCTs), clinical controlled tri-
als (CCTs), cross-sectional, case series (CSs), and case
reports (CRs). Reviews, editorials, popular science pa-
pers, and letters to the editor were not eligible. No limi-
tations were placed in terms of language or publication
type. Where multiple publications reporting the same
data were found, we included only the first publication
in our analysis.
Studies were eligible if they evaluated the therapeutic
effect or safety of SAHP. AHP studies that were con-
ducted outside of the summer period were excluded. We
placed no limitations on the types of disease or
condition, nor on the herbal ingredients, acupoints, or
time of SAHP application.
Comparisons
For RCT and CCT studies, acceptable comparisons were
no treatment, placebo, western medication, and other
TCM therapy. Combined therapy with SAHP and other
interventions compared with other interventions alone
were also included. Comparisons consisting of variations
of SAHP were also included, such as SAHP versus AHP,
or different application times, preparation types or
herbal formulae.
Identification and selection of studies
We searched six Chinese and English language electronic
databases from inception to March 11 2015: China
Network Knowledge Infrastructure (CNKI) (1911–
1978, 1979–2015) Chinese Scientific Journal Database
(VIP) (1989–2015), Wan Fang Database (1985–2015),
Chinese Biomedical Literature Database (Sino-Med)
(1978–2015), PubMed (1966–2015) and the Cochrane
Library (Issue 3, 2015). Some of these databases also
include unpublished sub-databases: CNKI includes
China Doctoral Thesis Full-text Database, China Masters’
Thesis Full-text Database, International Conference
Proceedings Database, and National Key Conference
Proceedings Database; while Wanfang database con-
tains Wanfang Patent Database, Database of Stan-
dards. Our search terms included “SAHP, sanfutie,
tianjiu”. The search strategies for each database are
shown in Additional file 1.
Six review authors were involved in study identifica-
tion and selection. FZ first screened titles and abstracts
using NoteExpress 2.9.8 and five authors (YJZ, YFL, DY,
KYG and JYL) then selected eligible studies. Each of the
five authors were assigned one fifth of the full text arti-
cles to conduct study eligibility independently. FZ
checked the eligibility of each included studies again.
Data extraction and analysis
We developed an electronic data extraction form using
Epidata 3.1, the extracted data are shown in Additional
file 2. This was piloted by eight authors (YFL, DY, KYG,
JYL, YJZ, RXY, JC, XXQ) who extracted data from a sam-
ple of 15 articles during the piloting phase. Data extraction
was then conducted by the same eight authors for the
remaining publications by dividing the retrieved publica-
tions equally. One author (FZ) checked the extracted data.
The extracted variables included full citations, study
design, participants (origin, sample size, gender, age,
and medical condition), details of SAHP (herbal in-
gredients, acupoints, treatment session, treatment
course, frequency), control treatments and outcome
(follow up, outcome type). Disagreements regarding
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study eligibility and data extraction were discussed
with one author (JPL).
These data were imported into SPSS and analyzed de-
scriptively using SPSS® (release 20.0, IBM, Armonk, NY,
USA) and Microsoft Excel (version 12.3.5, Microsoft,
Redmond, WA, USA). Descriptive statistics was based
on the type of variables. Categorical variables were re-
ported as frequencies and percentages. For continuous
variables, we used means and standard deviations for
parametric data and reported median and range for non-
parametric data.
Ethics
Since this study drew from publicly available data and
did not recruit human participants, ethical approval was
not required.
Results
General description of overall studies
A total of 5987 records were identified and abstracts
screened. Of these, the majority were excluded due to
duplication or being clearly irrelevant from the title or
abstract. Full texts for the remaining 1330 records were
retrieved to assess eligibility further and which eventu-
ally enabled 937 articles to be included for our analysis.
Of these, 932 (99.47 %) articles were published in
Chinese whilst 5 (0.53 %) were published in English. 31
(3.31 %) publications were conference full text papers
and 29 (3.10 %) were dissertations (Fig. 1).
The earliest publication was in 1977, which compared
SAHP with no treatment for chronic bronchitis and
which involved 40 patients from the community [15].
The second earliest publication was identified as a CS,
published in 1989 and which involved 580 asthma and
chronic bronchitis patients [16]. In terms of the quan-
tity of publications, this appeared to increase after
2003 (Fig. 2). Between 2009 and 2010, the number of
articles published almost doubled. Following 2010, in-
crease tendency in publications became relatively
stable between 2011 and 2014 with a peak of 151 re-
ports in 2014. For the year 2015, 7 studies involving 6
RCTs and one cross-sectional study were identified. How-
ever, since the year of 2015 was not yet completed at the
time of our literature search, we did not display data for
2015 in Fig. 2.
Of the 937 studies, one was conducted in Switzerland,
while the remaining studies were performed in China.
The 936 analyzed articles originated in almost over
China except to Hainan province, with top five provinces













2979 records after duplicates 
removed
1330 full-text articles assessed for 
eligibility
937 full-text articles included
1649 records excluded after 
screening the title and abstract: 
- Popular papers
- Reviews 
- Basic or mechanism studies
393 full-text articles excluded:
- No AHP intervention
- Not doing during Sanfu
- Translation version
Fig. 1 The Flowchart of including and excluding studies
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9.61 %), Zhejiang (74, 7.90 %), Jiangsu (73, 7.79 %),
Henan (66, 7.04 %) (Fig. 3).
Out of the 937 studies, 60 (6.40 %) were conference pa-
pers and dissertations. The remaining 877 (93.60 %) re-
ports were published in 213 different journals; with the
highest frequency of publications in Chinese-language
journals: Shanghai Journal of Acupuncture and Moxibus-
tion (31, 3.53 %), Guangming Journal of Chinese Medicine
(29, 3.31 %), Hubei Journal of Traditional Chinese Medi-
cine (22, 2.51 %), Chinese Acupuncture & Moxibustion (19,
2.17 %), Journal of Clinical Acupuncture and Moxibustion
(18, 2.05 %), Liaoning Journal of Traditional Chinese
Medicine (17, 1.94 %), Journal of New Chinese Medicine
(17, 1.94 %), Shanxi Journal of Chinese Medicine (17,
1.94 %), and Zhejiang Journal of Traditional Chinese
Medicine (16, 1.82 %). Only 5 studies had been published





1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Total 1 0 1 3 1 2 3 1 1 8 4 7 7 7 8 2 20 18 26 34 41 46 62 108 104 133 132 150
RCT 0 0 0 0 0 0 0 0 0 0 1 0 2 1 0 0 4 6 11 11 11 16 23 57 43 54 72 86
CCT 1 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 2 2 3 6 2 4 5 2 11 5 6
CS 0 0 1 3 1 2 2 1 1 8 2 7 5 6 6 2 15 10 12 20 23 28 34 41 55 64 53 56
CR 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 1 0 1 5 4 3 1 1
Cross
Sectional












Fig. 2 Numbers of studies on SAHP by study type between 1977 to 2014
Fig. 3 Data map of SAHP studies in China
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in international journals: American Journal of Chinese
Medicine (1 study) [17], Evidence-based Complementary
and Alternative Medicine (2 studies) [18, 19], and Journal
of Traditional Chinese Medicine (2 studies) [20, 21].
Study design
Amongst the 937 studies, there were 404 RCTs
(43.12 %), 52 CCTs (5.55 %), 458 CSs (48.88 %), 19 CRs
(2.03 %) and 4 cross-sectional studies (0.43 %). The first
RCT was published in 1997. 36 (3.84 %) studies were re-
ported as being multi-centered. When combining RCTs
and CCTs together, the majority (412, 90.35 %) featured
2 treatment arms, 39 (8.55 %) were designed as 3 arms,
and 5 (1.10 %) featured four arms.
Disease categories
The 937 studies included a total of 232,138 participants
and who were recruited from a number of settings in-
cluding the following: hospital (884, 94.34 %), commu-
nity health center (16, 1.71 %), clinic (2, 0.21 %) and
nursing home (1 study). 34 (3.63 %) studies did not pro-
vide details of setting. Study sample sizes of RCTs and
CCTs ranged from 19 to 1042. Thirty studies (3.20 %)
did not report the participants’ age. Most studies (696,
74.28 %) included adults (>18 years), 183 (19.53 %) stud-
ies only enrolled children and /or adolescents (<18 years),
7 studies enrolled older adults (>60 years), and 28
(2.99 %) studies involved participants of different ages.
Among the 772 studies which reported gender, the
proportion of male (52.57 %) and female (47.43 %) par-
ticipants were almost equal.
Amongst the studies, thirty-five different conditions
were treated and which can be seen in Table 1. The most
frequently reported were respiratory disorders with 742
(79.19 %) studies. The 10 highest ranking conditions
where SAHP was most frequently applied were asthma
(401, 42.80 %), chronic bronchitis (146, 15.58 %), allergic
rhinitis (117, 12.49 %), chronic obstructive pulmonary
disease (73, 7.79 %), recurrent respiratory tract infection
(42, 4.48 %), cough and panting (42, 4.48 %), knee osteo-
arthritis (23, 2.45 %), rheumatoid arthritis (15, 1.60 %),
common cold (8, 0.85 %), and sub-health (a condition
characterized by some disturbances in psychological or
physical characteristics but with no typical pathologic
features) (7, 0.75 %). The remaining 25 conditions were
found in less than 6 studies and among these 6, one
study alone featured 13 conditions. 9 studies did not re-
port a condition since the focus of the study was on side
effects or adverse events (Table 1).
Intervention categories
A total of 890 studies (94.98 %) reported sufficient infor-
mation regarding the season in which SAHP was applied
and treatment duration. In terms of the SAHP applica-
tion, 787 (88.43 %) studies reported applying only during
sanfu period, 103 (11.70 %) studies reported applying
during both sanfu and sanjiu period (winter season).
The remainder of the 47 studies mentioned applying
Table 1 Number of condition categories in clinical SAHP studies from 1977 to 2015 (n = 928)
Disease/condition Frequency Percentage Disease/condition Frequency Percentage
Asthma 401 43.21 Chronic Pelvic Inflammation 2 0.22
Chronic Bronchitis 146 15.73 Chronic Renal Failure 2 0.22
Allergic Rhinitis 117 12.61 Chronic Pulmonary Heart Disease 2 0.22
Chronic Obstructive Pulmonary Disease 73 7.87 Dysmenorrhea 2 0.22
Recurrent Respiratory Tract Infection 42 4.53 Postpartum Bodily Pain 1 0.11
Cough and panting 42 4.53 Pneumoconiosis 1 0.11
Knee Osteoarthritis 23 2.48 Tourette’s syndrome 1 0.11
Rheumatoid Arthritis 15 1.62 Night Sweat 1 0.11
Common Cold 8 0.86 Chronic Glomerulonephritis 1 0.11
Sub-health 7 0.75 Coronary Heart Disease 1 0.11
Irritable Bowel Syndrome 6 0.65 Rachitis 1 0.11
Chronic Pharyngitis 5 0.54 Scapulohumeral Periarthritis 1 0.11
Ankylosing Spondylitis 4 0.43 Insomnia 1 0.11
Diarrhea 4 0.43 Diabetic Nephropathy 1 0.11
Dyspepsia 4 0.43 Psoriasis 1 0.11
Chilblains 4 0.43 Primary Glomerulonephritis 1 0.11
Cervical Spondylosis 3 0.32 Lumbar Osteoarthritis 1 0.11
Pneumonia 3 0.32
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SAHP only during the summer. The most common
treatment course was one sanfu and which was reported
in 443 studies (50.34 %). 10 sanfus was the longest treat-
ment course reported in 1 study [22], with a median
length of 1 sanfu. The number of SAHP sessions per
sanfu were reported in a total of 871 studies (range: 3 to
40, median = 3 sessions), with the majority reporting 3
sessions (599 studies, 68.77 %).
Asthma was the most commonly treated condition
from the included studies. We focused our analysis of
SAHP acupoints and herbal ingredients on the 401
asthma studies. Complete information of acupoints and
herbal ingredients were available in 386 (95.55 %, report-
ing 1736 acupoints) and 362 (89.60 %, reporting 1833
herb ingredients) studies respectively. A total of 42 acu-
ponts were selected for SAHP and the five most com-
monly used acupoints were: BL13, EX-B1, GV14, RN22
and BL17. One hundred and two herbal ingredients were
reported and the five most frequently used herbs were:
Semen Sinapis (baijizi), Herba Asari (xixin), Radix Kan-
sui (gansui), Rhizoma Corydalis (yanhusuo) and Herba
Ephedrae (mahuang) (Table 2).
Comparison types
A total of 502 comparisons were reported in the 485
controlled clinical studies and which are shown in Fig. 4.
These 502 comparisons were classified into 6 different
comparisons: SAHP alone vs different treatments (16
subcategories, 275 comparisons), SAHP combined with
other TCM therapies vs different treatments (5 subcat-
egories, 26 comparisons), SAHP combined with non
pharmaceutical traditional Chinese therapy vs different
treatments (4 subcategories, 30 comparisons), SAHP
combined with western medicine vs different treatments
(4 subcategories, 70 comparisons), SAHP combined with
western medicine and TCM vs different treatments (4
subcategories, 20 comparisons), different characteristics
of SAHP comparisons (12 subcategories, 81 compari-
sons, patching during sanfu or not, different form of
SAHP, acupoint selected, formula, etc.). As no compari-
sons are reported in CS, CR and cross-sectional studies,
we analyzed the RCTs and CCTs for details on compari-
son treatments. The details of SAHP comparison cat-
egories can be found in the Fig. 4.
Outcomes
Of the 937 studies, 740 studies reported sufficient infor-
mation regarding the outcome measure. 373 (50.41 %)
studies stated that the outcome was evaluated immedi-
ately after SAHP; and 321 (43.38 %) studies evaluated
the effects after a follow up period; the remaining 46
(6.22 %) studies reported measuring the outcome post
SAHP and at follow up. The reported follow-up fre-
quency ranged from 1 to 5 times (once a year, a total of
five years), with a median of once; whereas the follow-up
period ranged from 10 days to 36 months, with a median
of 12 months.
The most frequently reported outcome measures were
laboratory indices (262 studies, 35.41 %), followed by
safety (241 studies, 32.57 %), clinical symptom (205
studies, 27.70 %), quality of life (48 studies, 6.49 %), sat-
isfaction of patients (1 study) and economic index (1
study). 512 studies (69.19 %) used composite outcome
measures for clinical effectiveness by incorporating sev-
eral outcome components into one comprehensive cat-
egory (Fig. 5).
Discussion
This bibliometric analysis has comprehensively identified
and analyzed clinical studies of SAHP, and included 937
reports mainly from China with one study from
Switzerland [23]. Whilst the earliest study did not com-
mence until 1977, the majority appeared after 2003 with
multi-fold increase in RCTs and CSs. The quantity of
studies on SAHP has increased during the last 40 years.
Although there was a slight reduction in 2011 of publi-
cations in SAHP, the overall trend appears to be that the
number of studies is continuing to increase. The total
number of studies published in 2014 was three times
more than that in 2008. In addition, there were 5 studies
published in 3 international journals [17–21]; suggesting
that SAHP, a therapy conducted predominantly in
China, is being promoted to an international audience.
CS was the most frequently used study design
(48.88 %). This may be due to the ease of conducting a
CS since the absence of a control group means smaller
sample sizes are required and avoids the requirement for
large numbers of SAHP treatment to be carried out in
the same period. RCT constituted 43.12 % of the study
designs and which is considered a reliable design for the
evaluation of a medical therapy. However, the quality of
these RCTs may have been poor. In our previous sys-
tematic review on AHP for stable chronic obstructive
pulmonary disease (COPD) and allergic rhinitis (AR)
[24, 25], the methodology quality of the included RCTs
was generally poor; suggesting that further well-designed
RCTs of AHP for COPD and AR is needed. However, we
did not conduct an assessment for methodological qual-
ity in this present analysis and it is possible that this will
be the next phase of our research.
The included studies had 232,138 participants without
gender bias and with sufficient representation across dif-
ferent age groups (from 2 to 90 years). 20 % of the stud-
ies focused only on children and adolescents. Diseases
or conditions treated by SAHP covered 35 categories;
the most frequently reported was respiratory diseases, of
which asthma was the top one. These findings indicate
that SAHP might yield potential advantages for treating
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Table 2 Details SAHP intervention. Frequency and percentage of details applied season, treatment course, treatment sessions per sanfu, herb ingredient, acupoint selected of
SAHP intervention




Herb ingredient (362 studies with sufficient information) Herb ingredient (362 studies
with sufficient information)
Only in sanfu 787 88.43 Semen Sinapis 351 96.96 Radix et Rhizoma
Salviae Miltiorrhizae
5 1.38




Radix Kansui 297 82.04 Others 84 23.20
1 sanfu 453 50.90 Rhizoma Corydalis 269 74.31
2 sanfus 40 4.49 Herba Ephedrae 80 22.10 Acupoint selected (386 studies
with sufficient information)
3 sanfus 289 32.47 Cortex Cinnamomi 57 15.75 BL 13 374 96.89
5 sanfus 4 0.45 Moschus 54 14.92 EX-B1 195 50.52
10 sanfus 1 0.11 Rhizoma Pinelliae 44 12.15 DU 14 160 41.45
1 sanfu and sanjiu 61 6.85 Borneolum Syntheticum 27 7.46 RN 22 140 36.27
2 sanfus and sanjius 9 1.01 Flos Caryophylli 25 6.91 BL 17 130 33.68
3 sanfus and sanjius 33 3.71 Radix Aconiti Lateralis
Praeparata
24 6.63 BL 15 118 30.57
Treatment sessions per sanfu
(871 studies with sufficient
information)
Fructus Perillae 18 4.97 RN 17 117 30.31
4 times 45 5.17 Radix Angelicae Dahuricae 14 3.87 BL 23 114 29.53
5 times 43 4.94 Pheretima 13 3.59 BL 43 104 26.94
6 times 86 9.87 Fructus Evodiae 12 3.31 BL 20 88 22.80
7 times 2 0.23 Radix Saposhnikoviae 10 2.76 BL 12 64 16.58
8 times 15 1.72 Radix et Rhizoma Asari 10 2.76 ST 36 25 6.48
9 times 34 3.90 Pericarpium Zanthoxyli 9 2.49 EX-HN15 17 4.40
10 times 14 1.61 Flos Daturae 9 2.49 BL 11 15 3.89
12 times 6 0.69 Fructus Gleditsiae 9 2.49 ST 40 10 2.59
15 times 7 0.80 Radix Astragali 8 2.21 BL 21 7 1.81
16 times 2 0.23 Mylabris 7 1.93 LU 1 7 1.81
18 times 6 0.69 Semen Raphani 7 1.93 BL 52 6 1.55
20 times 3 0.34 Fructus Schisandrae Chinensis 7 1.93 BL 14 5 1.30
24 times 3 0.34 Lignum Aquilariae Resinatum 6 1.66 RN 6 5 1.30
28 times 1 0.11 Rhizoma Chuanxiong 6 1.66 Others 31 8.03
30 times 2 0.23 Radix Scutellariae 6 1.66


















respiratory disease with different gender and ages. How-
ever, this needs requires a systematic review and meta-
analysis to be conducted in order to robustly identify
any potential benefits.
It is not difficult to see the diversities in SAHP, such as
varying frequency of treatment sessions, length of treat-
ment course and acupoints or herbal ingredients. How-
ever, our analysis found that 3 sessions in one sanfu
period was most commonly used in the included studies.
However, it is difficult to confirm whether or not this is
the most appropriate treatment arrangement. Indeed,
comparisons of different treatment arrangements was
the research question for some studies included in our
analysis. Hence, we would recommend that future sys-
tematic reviews should evaluate frequency of treatment
sessions, length of treatment course and other character-
istics of SAHP in order to be able to provide stronger
recommendations regarding best practice in SAHP.
Outcome evaluation was conducted at the end of
SAHP treatment in 373 studies, which we regard un-
reasonable in order to assess the effectiveness of
SAHP. This is because SAHP is used to treat winter
conditions and we regard the most appropriate time
for outcome assessment should therefore be in the
winter or early spring. Furthermore 69.19 % studies
applied composite outcome measures rather than
internationally-validated outcomes and which limits
the interpretations of our findings. Furthermore mea-
sures such as quality of life, patient satisfactory and
economic outcome were rarely used. Further research
Fig. 4 Number of different comparison categories and subcategories in clinical studies. n = number of comparisons; others = subcategory that
only appear once. WM: Western medicine; TCM: traditional Chinese medicine; NPTCT: Non pharmaceutical traditional Chinese therapy; NPWT: Non
pharmaceutical western therapy
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should therefore incorporate these in order to evaluate
its cost-effectiveness for less affluent societies or for
large scale application by commissioning groups.
This bibliometric analysis has several limitations.
Firstly severity and course of disease or condition were
not extracted in this analysis. Second, did not analyze
the journal impact factor and citation per papers. Finally
the methodological and reporting quality of included
studies was not evaluated.
Conclusion
To our knowledge, this analysis presents the most
complete summary of clinical SAHP studies published to
date, and can offer patients, physicians and researchers a
more complete assessment of how SAHP is commonly
used. Our findings show PICOS (participant, interven-
tion, comparison, outcome and study design) character-
istics of SAHP studies in the past 40 years and which
can offer researchers an insight into formulating appro-
priate research questions for the evaluation of SAHP.
Other bibliometric indices also show the research
status in this field. We found that research output on
SAHP is gradually increasing and that most research is
being conducted in China. This suggests that SAHP re-
mains largely unknown in other countries. In addition, 5
studies published on international English-language
journals may begin to attract interest from research
groups internationally.
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